Merck Canada president and managing director Marwan Akar said Monday that the Thermo Fisher Scientific plant in Whitby, Ont., will be ready to begin manufacturing and supplying Molnupiravir, Merck’s COVID-19 antiviral treatment, soon after receiving approval from Health Canada.
Canada
Whitby’s Thermo Fisher Scientific plant ready to begin supplying Molnupiravir upon approval, Merck says
More Videos
-
Loblaw boycott: Small grocers, co-ops seeing boost
-
Cancelled carbon capture project casts doubt on Canada’s climate plan
-
Is the government of India behind a global campaign against Sikh separatism?
-
Is there a connection between India and a notorious gang?
-
Hardeep Singh Nijjar: Arrests in case raise Canadian national security concerns
-
Canada’s women hockey players battle for ultimate Walter Cup prize
You are viewing an Accelerated Mobile Webpage.
View Original Article